The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 14, 2025
Filed:
Dec. 19, 2023
Applicant:
Hangzhou Polymed Biopharmaceuticals, Inc., Zhejiang, CN;
Inventors:
Jason Shaoyun Xiang, Zhejiang, CN;
Lei Wu, Zhejiang, CN;
Rui Xu, Zhejiang, CN;
Qiang Zhang, Zhejiang, CN;
Gang Yang, Zhejiang, CN;
Michael Xiang, Zhejiang, CN;
Mixue Tong, Zhejiang, CN;
Camille Xiang, Zhejiang, CN;
Yuxin Liu, Zhejiang, CN;
Suyue Wang, Zhejiang, CN;
Rui Yang, Zhejiang, CN;
Assignee:
HANGZHOU POLYMED BIOPHARMACEUTICALS, INC., Zhejiang, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 498/08 (2006.01); A61K 31/422 (2006.01); A61K 31/437 (2006.01); A61K 31/439 (2006.01); A61K 31/4439 (2006.01); A61K 31/4545 (2006.01); A61K 31/496 (2006.01); A61K 31/4985 (2006.01); A61K 31/5377 (2006.01); A61K 31/5386 (2006.01); A61P 35/02 (2006.01); C07D 401/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 471/08 (2006.01); C07D 487/04 (2006.01); C07D 491/107 (2006.01); C07D 493/08 (2006.01); C07D 498/04 (2006.01); C07D 513/04 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 498/08 (2013.01); A61K 31/422 (2013.01); A61K 31/437 (2013.01); A61K 31/439 (2013.01); A61K 31/4439 (2013.01); A61K 31/4545 (2013.01); A61K 31/496 (2013.01); A61K 31/4985 (2013.01); A61K 31/5377 (2013.01); A61K 31/5386 (2013.01); A61P 35/02 (2018.01); C07D 401/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 471/08 (2013.01); C07D 487/04 (2013.01); C07D 491/107 (2013.01); C07D 493/08 (2013.01); C07D 498/04 (2013.01); C07D 513/04 (2013.01); C07D 519/00 (2013.01);
Abstract
A five-membered-fused six-membered compound, and a preparation method therefor and a pharmaceutical composition and the use thereof. The five- and six-membered compound is a compound as shown in formula I, II or III. The compound has an inhibitory effect on FLT3 and/or IRAK4.